Houston (1)

Central Nervous System Lymphoma (1)

Gastric Mantle Cell Lymphoma (1)

Recurrent Mantle Cell Lymphoma (1)

Recurrent Non-Hodgkin Lymphoma (1)

Refractory Mantle Cell Lymphoma (1)

Refractory Non-Hodgkin Lymphoma (1)

Splenic Mantle Cell Lymphoma (1)

Terminated (1)

phase 1/phase 2 (1)

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

akt/erk inhibitor onc201 (1)

laboratory biomarker analysis (1)

pharmacological study (1)

drug (1)

other (1)

Other (1)

Interventional (1)

splenic mantle cell lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Terminated

Mar 30, 2022